Gastro Esophageal Junction Cancer Completed Phase 3 Trials for Napabucasin (DB12155)

Also known as: Gastroesophageal-junction Cancer / Gastroesophageal Junction Cancer / Gastro-oesophageal Junction Cancer / Gastro-esophageal Junction Cancer / Gastrooesophageal junction cancer / Carcinoma of oesophagus NOS / Carcinoma of oesophagus / Carcinoma of esophagus (disorder) / Carcinoma of esophagus / Oesophageal carcinoma NOS / Oesophageal carcinoma / Esophageal carcinoma NOS / Esophageal carcinoma / Primary malignant neoplasm of esophagus (disorder)

IndicationStatusPhase
DBCOND0106887 (Gastro Esophageal Junction Cancer)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02178956A Study of BBI608 Plus Weekly Paclitaxel to Treat Gastric and Gastro-Esophageal Junction CancerTreatment